MY103212A - Zinc-protamine-alpha interferon complex - Google Patents

Zinc-protamine-alpha interferon complex

Info

Publication number
MY103212A
MY103212A MYPI88000169A MYPI19880169A MY103212A MY 103212 A MY103212 A MY 103212A MY PI88000169 A MYPI88000169 A MY PI88000169A MY PI19880169 A MYPI19880169 A MY PI19880169A MY 103212 A MY103212 A MY 103212A
Authority
MY
Malaysia
Prior art keywords
alpha interferon
protamine
zinc
interferon complex
complex
Prior art date
Application number
MYPI88000169A
Other languages
English (en)
Inventor
A Zupon Michael
A Chaudry Imtiaz
Yim Zachary
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of MY103212A publication Critical patent/MY103212A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
MYPI88000169A 1987-02-24 1988-02-19 Zinc-protamine-alpha interferon complex MY103212A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/018,243 US4853218A (en) 1987-02-24 1987-02-24 Zinc-protamine-alpha interferon complex

Publications (1)

Publication Number Publication Date
MY103212A true MY103212A (en) 1993-05-29

Family

ID=21786960

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI88000169A MY103212A (en) 1987-02-24 1988-02-19 Zinc-protamine-alpha interferon complex

Country Status (23)

Country Link
US (1) US4853218A (enExample)
EP (2) EP0281299B1 (enExample)
JP (1) JPH0611712B2 (enExample)
KR (1) KR940001372B1 (enExample)
AT (1) ATE76580T1 (enExample)
AU (1) AU608584B2 (enExample)
CA (1) CA1316105C (enExample)
DE (1) DE3871407D1 (enExample)
DK (1) DK167048B1 (enExample)
ES (1) ES2032009T3 (enExample)
FI (1) FI93309C (enExample)
GR (1) GR3005358T3 (enExample)
HU (1) HU201881B (enExample)
IE (1) IE61340B1 (enExample)
IL (1) IL85523A (enExample)
MX (1) MX9203328A (enExample)
MY (1) MY103212A (enExample)
NO (1) NO173279C (enExample)
NZ (1) NZ223598A (enExample)
OA (1) OA09737A (enExample)
PT (1) PT86810B (enExample)
WO (1) WO1988006456A1 (enExample)
ZA (1) ZA881258B (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028422A (en) * 1986-05-27 1991-07-02 Schering Corporation Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
DK264787A (da) * 1986-05-27 1987-11-28 Schering Corp Anvendelse af humant alfa-interferon til fremstilling af et pharmaceutisk praeparat
ATE90205T1 (de) * 1987-09-08 1993-06-15 Takeda Chemical Industries Ltd Wasserunloesliche cytokine.
CA2084406A1 (en) * 1990-06-04 1991-12-05 Paul Reichert Method for preparing interferon alpha-2 crystals
US5912015A (en) 1992-03-12 1999-06-15 Alkermes Controlled Therapeutics, Inc. Modulated release from biocompatible polymers
US5711968A (en) * 1994-07-25 1998-01-27 Alkermes Controlled Therapeutics, Inc. Composition and method for the controlled release of metal cation-stabilized interferon
US6514533B1 (en) 1992-06-11 2003-02-04 Alkermas Controlled Therapeutics, Inc. Device for the sustained release of aggregation-stabilized, biologically active agent
EP1013270A3 (en) * 1992-12-02 2001-03-28 Alkermes Controlled Therapeutics, Inc. Controlled release growth hormone containing microspheres
US5441734A (en) * 1993-02-25 1995-08-15 Schering Corporation Metal-interferon-alpha crystals
US6087324A (en) * 1993-06-24 2000-07-11 Takeda Chemical Industries, Ltd. Sustained-release preparation
AU706180B2 (en) * 1994-07-25 1999-06-10 Alkermes Controlled Therapeutics, Inc. Controlled release of metal cation-stabilized interferon
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
JP3837769B2 (ja) * 1995-06-12 2006-10-25 大塚製薬株式会社 抗ウイルス剤
WO1997007788A2 (en) * 1995-08-31 1997-03-06 Alkermes Controlled Therapeutics, Inc. Composition for sustained release of an agent
CN1146402C (zh) * 1996-12-20 2004-04-21 阿尔萨公司 凝胶组合物及方法
US6465425B1 (en) 2000-02-10 2002-10-15 Alkermes Controlled Therapeutics, Inc. Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
US20030211974A1 (en) * 2000-03-21 2003-11-13 Brodbeck Kevin J. Gel composition and methods
CA2466632C (en) * 2001-11-14 2014-02-11 Alza Corporation Injectable depot compositions and uses thereof
US20070196415A1 (en) * 2002-11-14 2007-08-23 Guohua Chen Depot compositions with multiple drug release rate controls and uses thereof
AU2002359407B2 (en) * 2001-11-14 2008-02-28 Durect Corporation Catheter injectable depot compositions and uses thereof
CA2466642C (en) * 2001-11-14 2011-01-18 Guohua Chen Injectable depot composition
TWI353854B (en) 2002-06-25 2011-12-11 Alza Corp Short duration depot formulations
US20040001889A1 (en) * 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
ES2319400T3 (es) * 2002-07-31 2009-05-07 Durect Corporation Composiciones deposito inyectables y empleo de las mismas.
ATE419831T1 (de) 2002-07-31 2009-01-15 Alza Corp Injizierbare multimodale polymere depotzusammensetzungen und ihre verwendungen
DE60325511D1 (de) * 2002-11-06 2009-02-05 Alza Corp Depot-formulierungen mit verzögerter freisetzung
WO2004060920A1 (en) * 2002-12-31 2004-07-22 Altus Pharmaceuticals Inc. Complexes of protein crystals and ionic polymers
JP4686361B2 (ja) * 2002-12-31 2011-05-25 アルタス ファーマシューティカルズ インコーポレイテッド ヒト成長ホルモンの結晶およびその調製方法
CN1822816A (zh) * 2003-05-30 2006-08-23 阿尔萨公司 可植入的弹性体储库组合物、其用途以及制备方法
US20070184084A1 (en) * 2003-05-30 2007-08-09 Guohua Chen Implantable elastomeric caprolactone depot compositions and uses thereof
US20050106214A1 (en) * 2003-11-14 2005-05-19 Guohua Chen Excipients in drug delivery vehicles
US20050281879A1 (en) * 2003-11-14 2005-12-22 Guohua Chen Excipients in drug delivery vehicles
US7812049B2 (en) * 2004-01-22 2010-10-12 Vicept Therapeutics, Inc. Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists
US20060142234A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
JP2009521486A (ja) * 2005-12-23 2009-06-04 アルタス ファーマシューティカルズ インコーポレイテッド ポリカチオン錯化タンパク質結晶を含む組成物およびこれを使用した治療法
US7753077B2 (en) 2007-04-19 2010-07-13 Husco International Inc. Hybrid hydraulic joystick for electrically operating valves
US7753078B2 (en) 2007-04-19 2010-07-13 Husco International Inc. Hybrid hydraulic joystick with an integral pressure sensor and an outlet port
JP4889782B2 (ja) * 2008-12-24 2012-03-07 株式会社マルハニチロ食品 プロタミン及び／またはその塩と酸性高分子化合物とを含む生理活性複合体及びその用途
NZ594248A (en) * 2009-01-28 2015-03-27 Smartcells Inc Conjugate based systems for controlled drug delivery
EA026964B1 (ru) * 2010-11-24 2017-06-30 Дьюрект Корпорейшн Биоразлагаемая композиция для доставки лекарственного средства (варианты)
WO2015088990A1 (en) 2013-12-09 2015-06-18 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
BR112022013784A2 (pt) 2020-01-13 2022-10-11 Durect Corp Sistemas de distribuição de fármacos de liberação prolongada com impurezas reduzidas e métodos relacionados
KR20230145053A (ko) 2021-01-12 2023-10-17 듀렉트 코퍼레이션 지속 방출 약물 전달 시스템 및 관련 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1282504A (fr) * 1954-06-03 1962-01-27 Novo Terapeutisk Labor As Procédé de production de suspensions stables d'insuline zinc-protamine
US3912807A (en) * 1974-04-18 1975-10-14 American Home Prod Treatment of diabetes using somatostatin and insulin
IN150740B (enExample) * 1978-11-24 1982-12-04 Hoffmann La Roche
PH21848A (en) * 1980-01-08 1988-03-17 Biogen Nv Dna sequences and recombinant dna molecules
ES506955A0 (es) * 1980-11-10 1983-02-01 Genentech Inc Un procedimiento para producir un polipeptido antiviral.
DE3262575D1 (en) * 1981-12-23 1985-04-18 Schering Corp Stabilised interferon formulations and their preparation
US4605555A (en) * 1984-09-20 1986-08-12 Sun Star Kabushiki Kaisha Composition and method for treating keratosic disorder of skin and mucosa

Also Published As

Publication number Publication date
AU608584B2 (en) 1991-04-11
FI893929L (fi) 1989-08-22
HUT51902A (en) 1990-06-28
JPH0611712B2 (ja) 1994-02-16
OA09737A (en) 1993-11-30
DE3871407D1 (de) 1992-07-02
FI93309C (fi) 1995-03-27
KR890700359A (ko) 1989-04-24
ZA881258B (en) 1988-08-23
NO173279C (no) 1993-11-24
NO884596D0 (no) 1988-10-14
PT86810A (pt) 1988-03-01
EP0375678A1 (en) 1990-07-04
AU1394688A (en) 1988-09-26
NZ223598A (en) 1989-12-21
DK167048B1 (da) 1993-08-23
DK582188D0 (da) 1988-10-19
HU201881B (en) 1991-01-28
GR3005358T3 (enExample) 1993-05-24
IL85523A0 (en) 1988-08-31
MX9203328A (es) 1992-07-01
NO884596L (no) 1988-10-14
KR940001372B1 (ko) 1994-02-21
DK582188A (da) 1988-10-19
EP0281299A1 (en) 1988-09-07
CA1316105C (en) 1993-04-13
FI93309B (fi) 1994-12-15
WO1988006456A1 (en) 1988-09-07
EP0281299B1 (en) 1992-05-27
IL85523A (en) 1992-11-15
IE61340B1 (en) 1994-11-02
NO173279B (no) 1993-08-16
IE880480L (en) 1988-08-24
ES2032009T3 (es) 1993-01-01
FI893929A0 (fi) 1989-08-22
US4853218A (en) 1989-08-01
ATE76580T1 (de) 1992-06-15
PT86810B (pt) 1992-05-29
JPH03500286A (ja) 1991-01-24

Similar Documents

Publication Publication Date Title
MY103212A (en) Zinc-protamine-alpha interferon complex
HUT69178A (en) Process for producing peptides of growth hormone releasing activity
ZA879173B (en) Therapeutic agents
ZA885944B (en) Transdermal therapeutic system
KR950702120A (ko) 골다공증 치료를 위한 포스포네이트의 용도(use of phosphonates for the treatment of osteoporosis)
ES2002083A6 (es) Un metodo para preparar derivados de piroglutamida
DE3676997D1 (de) Theophyllintabletten mit verzoegerter freigabe.
IL92180A (en) Pharmaceutical composition for preventing or reducing eosinophilia
AU1768188A (en) Pharmaceutical compositions
DE3766885D1 (en) Chlorpheniramine therapie.
ATE22531T1 (de) Pharmazeutische zusammenstellung fuer induktion von cytoprotektion.
GR3006999T3 (enExample)
GR3018837T3 (en) Subcutaneous administration of human chorionic gonadotrophin.
BG60697B2 (en) Medicamentous form having continous release based on ethodolacquer
MY106292A (en) (alpha)-adrenergic receptor antagonists.
JO1461B1 (en) Therapeutic agents
GB8718805D0 (en) Article for administering medicine
IE862241L (en) Injectable sustained release formulation
IE893010L (en) Administering epostane to swine